SEK175.70
0.11% today
Stockholm, Apr 04, 12:02 pm CET
ISIN
SE0010323311
Symbol
BIOA B
Sector
Industry

BioArctic AB Target price 2025 - Analyst rating & recommendation

BioArctic AB Classifications & Recommendation:

Buy
83%
Hold
17%

BioArctic AB Price Target

Target Price SEK318.83
Price SEK175.50
Potential
Number of Estimates 6
6 Analysts have issued a price target BioArctic AB 2026 . The average BioArctic AB target price is SEK318.83. This is higher than the current stock price. The highest price target is
SEK360.00 105.13%
register free of charge
, the lowest is
SEK240.00 36.75%
register free of charge
.
A rating was issued by 6 analysts: 5 Analysts recommend BioArctic AB to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioArctic AB stock has an average upside potential 2026 of . Most analysts recommend the BioArctic AB stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million SEK 257.35 1,663.62
58.22% 546.44%
Net Margin -68.69% 58.78%
284.13% 185.57%

7 Analysts have issued a sales forecast BioArctic AB 2025 . The average BioArctic AB sales estimate is

SEK1.7b
Unlock
. This is
546.44% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
SEK2.2b 735.44%
Unlock
, the lowest is
SEK574m 123.04%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 SEK257m 58.22%
2025
SEK1.7b 546.44%
Unlock
2026
SEK1.6b 6.25%
Unlock
2027
SEK2.6b 67.76%
Unlock
2028
SEK4.0b 53.73%
Unlock
2029
SEK5.3b 30.91%
Unlock

3 BioArctic AB Analysts have issued a net profit forecast 2025. The average BioArctic AB net profit estimate is

SEK978m
Unlock
. This is
653.17% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
SEK1.0b 679.00%
Unlock
, the lowest is
SEK933m 628.00%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 SEK-177m 176.92%
2025
SEK978m 653.17%
Unlock
2026
SEK593m 39.35%
Unlock
2027
SEK1.3b 125.78%
Unlock

Net Margin

2024 -68.69% 284.13%
2025
58.78% 185.57%
Unlock
2026
38.03% 35.30%
Unlock
2027
51.18% 34.58%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share SEK -2.00 11.06
176.92% 653.00%
P/E 15.86
EV/Sales 9.06

3 Analysts have issued a BioArctic AB forecast for earnings per share. The average BioArctic AB EPS is

SEK11.06
Unlock
. This is
653.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
SEK11.58 679.00%
Unlock
, the lowest is
SEK10.56 628.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 SEK-2.00 176.92%
2025
SEK11.06 653.00%
Unlock
2026
SEK6.71 39.33%
Unlock
2027
SEK15.15 125.78%
Unlock

P/E ratio

Current -87.55 205.72%
2025
15.86 118.12%
Unlock
2026
26.15 64.88%
Unlock
2027
11.58 55.72%
Unlock

Based on analysts' sales estimates for 2025, the BioArctic AB stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 58.59 96.54%
2025
9.06 84.53%
Unlock
2026
9.67 6.67%
Unlock
2027
5.76 40.39%
Unlock
2028
3.75 34.95%
Unlock
2029
2.86 23.61%
Unlock

P/S ratio

Current 60.37 96.06%
2025
9.34 84.53%
Unlock
2026
9.96 6.67%
Unlock
2027
5.94 40.39%
Unlock
2028
3.86 34.95%
Unlock
2029
2.95 23.61%
Unlock

Current BioArctic AB Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RX SECURITIES
Locked
Locked
Locked Jan 05 2025
DNB MARKETS
Locked
Locked
Locked Nov 17 2024
Analyst Rating Date
Locked
RX SECURITIES:
Locked
Locked
Jan 05 2025
Locked
DNB MARKETS:
Locked
Locked
Nov 17 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today